Modal Title

How will my information be used?

When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.

If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.

In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.

Departments & Organizations

Biography

Dr. Vincent DeVita, the Amy and Joseph Perella Professor of Medicine at the Yale Cancer Center and Professor of Epidemiology and Public Health, was the Director of the Yale Cancer Center from 1993 to 2003. He spent the early part of his career at the National Cancer Institute (NCI), and in 1980, the President of the United States appointed him director of the NCI and the National Cancer Program, a position he held until 1988. From 1988 until be returned to Yale in 1993, he was Physician-in-Chief and Attending Physician at Memorial Sloan Kettering Cancer Center and a member of the Program of Molecular Pharmacology. Dr. DeVita has earned international recognition for his accomplishments as a pioneer in the field of Oncology. While at the NCI, he was instrumental in developing combination chemotherapy programs that ultimately led to an effective regimen of curative chemotherapy for Hodgkin's disease and diffuse large cell lymphomas. Along with colleagues at the NCI, he developed the four-drug combination, known by the acronym MOPP, which increased the cure rate for patients with advanced Hodgkin's disease from nearly zero to over 70%. In addition, in collaboration with Dr. George Canellos, he developed the combination chemotherapy CMF, which still remains a useful therapy for breast cancer. He earned his Bachelor of Science degree from the College of William and Mary in 1957. He was awarded his M.D. degree with distinction from the George Washington University School of Medicine in 1961. Dr. DeVita currently serves on the editorial boards of numerous scientific journals and is the author or co-author of more than 450 scientific articles. He is one of the three editors of "Cancer: Principles and Practice of Oncology" and serves as the Editor-in-Chief of The Cancer Journal and Nature Reviews Clinical Oncology.

Education & Training

MD

George Washington University (1961)

Resident

Yale-New Haven Hospital

Fellow

National Cancer Institute, National Institute of Health

Senior Resident

George Washington U, DC General Hospital

Resident Intern

Univeristy of Michigan Medical Center

Honors & Recognition

Fellow of the American Association for Cancer Research (FAACR)AACR (2014)

Honorary Life MemberAmerican Cancer Society (2013)

Giants of Cancer Care 2013OncLive (2013)

President American Cancer SocietyACS (2012)

Fellow of the American Society of Clinical Oncology (FASCO)ASCO (2012)

Awarded Honoris Causa in Medicine Degree National University of Athens, Greece (2009)

Thesis Committee Member Pathology Department
Yale University School of Medicine (2005 - 2007)

Campaign Committee
Smilow Cancer Hospital at Yale-New Haven (2007)

Evaluation/Review Committee
Department of Epidemiology and Public Health, School of Public Health (2008)

International Activity

Cancer: Principles and Practices of Oncology
United States (2008)

Professor DeVita is one of three editors of CANCER: Principles &Practices of Oncology, coming into its tenth edition. CANCER is a comprehensive textbook in the field of cancer medicine; it is the most widely-read text on cancer in the world (and notably in Europe, India, and Asia). The textbook is...